Early Rasagiline Therapy Shows Long-term Benefits for Parkinson's

In an open label study, positive effects of early rasagiline monotherapy in patients with Parkinson's disease were maintained for up to 6.5 years.Yael Waknine

Continue to Early Rasagiline Therapy Shows Long-term Benefits for Parkinson's on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz